샘플 요청 목록

 카트 문의
시장보고서
상품코드
1721644

단백질체학 바이오마커 분석 시장(제2판) : 용도별, 기술별, 제품별, 장소별 예측 - 경영진 및 컨설턴트 가이드와 인공지능의 영향(2025-2029년)

Proteomic Biomarker Analytics Markets 2nd Edition. Forecasts by Application, Technology, Product and Place. With Executive and Consultant Guides. 2025 to 2029. Includes Impact of Artificial Intelligence
발행일: | 리서치사: Howe Sound Research | 페이지 정보: 영문 307 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유전체학에서 모든 답을 찾지 못하는 곳에 단백질체학이 다가갑니다.

누가 단백질체학의 Illumina가 될 것인가요? 새로운 바이오마커가 질병의 정의를 재정의할 것인가요? 단백질체학 분석이 현재의 유전체 분석을 대체할 것인가? 이 종합적인 보고서에서 이 모든 것을 밝혀내고 있습니다.

단백질체학 바이오마커 분석은 아직 시작에 불과하지만, 그 기회는 큽니다. 업체들은 두 자릿수 성장을 보고하고 있습니다. 벤처 캐피털도 뛰어들고 있습니다. 과제와 전망을 포함하여 다양한 시장 부문에 대해 5년 후 시장 규모를 예측하고 있습니다.

최신 데이터를 활용하여 확신을 가지고 투자 판단과 평가를 합니다.

세계의 단백질체학 바이오마커 분석 시장에 대해 조사했으며, 시장 개요와 함께 용도별, 기술별, 제품별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 시장 가이드

제2장 소개와 시장 정의

  • 단백질체학 바이오마커 분석이란 무엇인가?
  • 단백질체학과 의약품 개발
  • 시장 정의
  • 조사 방법

제3장 단백질체학 바이오마커 분석 - 기술 가이드

  • 방법
    • 분리 기술과 전기영동
    • 질량 분석
    • 크로마토그래피
    • 블롯팅
    • 단백질 상보 어세이와 상호작용 스크리닝
    • 단백질 구조 예측
    • 단백질 데이터베이스

제4장 업계 개요

  • 시장 진입 조직
  • 학술연구기관
  • 진단 시험 개발자
  • 계측 기기 공급업체
  • 약품·시약 제조업체
  • 병리 공급업체
  • 독립계 임상 검사실
  • 공공 국립/지역 연구소
  • 병원 검사실
  • 임상 검사실

제5장 시장 동향

  • 성장 촉진요인
  • 성장 억제요인

제6장 단백질체 해석의 최근 동향

제7장 주요 단백질체학 바이오마커 분석 기업 개요

  • Abbott Laboratories
  • Abcam
  • Agilent
  • Amprion
  • ATUM
  • BasePair Biotechnologies
  • Beckman Coulter Diagnostics(Danaher)
  • Becton, Dickinson and Company
  • Biomatik
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Bruker
  • C2N Diagnostics
  • Cepheid(Danaher)
  • Diadem Diagnostics
  • Eve Technologies
  • Fujirebio
  • Hybrigenics Services
  • MRM Proteomics Inc.
  • NanoDx
  • Nautilus Biotechnology
  • Nicoya
  • Nuclera
  • Olink
  • Qiagen
  • Quanterix
  • Roche Diagnostics
  • Second Genome
  • Siemens Healthineers
  • Sphingotec
  • Thermo Fisher Scientific
  • Unchained Labs

제8장 세계의 단백질체학 바이오마커 분석 시장

  • 국가별 세계 시장 - 개요
  • 용도별 세계 시장 - 개요
  • 기술별 세계 시장 - 개요
  • 제품별 세계 시장 - 개요
  • 장소별 세계 시장 - 개요

제9장 세계의 단백질체학 바이오마커 분석 시장 - 용도별

  • Drug Discovery
  • 연구
  • 임상 진단
  • 기타

제10장 세계의 단백질체학 바이오마커 분석 시장 - 기술별

  • 질량 분석
  • ELISA/비즈
  • 하이브리드 멀티플렉스
  • 기타

제11장 세계의 단백질체학 바이오마커 분석 시장 - 제품별

  • 기기
  • 키트와 시약
  • 서비스

제12장 세계의 단백질체학 바이오마커 분석 시장 - 장소별

  • 학술기관
  • 제약/바이오테크놀러지
  • 임상
  • 기타

제13장 부록

ksm 25.05.28

Where genomics can't find all the answers proteomics is stepping up to the plate.

Who will be the Illumina of Proteomics? Will these new biomarkers redefine disease definitions? Will Proteomic Assays displace current Genomic Assays? Find out all about it and more in this comprehensive report.

Proteomic Biomarker Analytics is just finding its feet, but the opportunity is huge. Players are reporting double digit growth. Venture capital is well involved. Learn about this market including the issues and outlooks. This technology could possibly displace most cancer diagnostic protocols AND save money at the same time. The report forecasts the market size out for five years for a number of different market segments.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants
  • 1.4. Impact of Artificial Intelligence

2. Introduction and Market Definition

  • 2.1. What are Proteomic Biomarker Analytics?
  • 2.2. Proteomics and Drug Development
  • 2.3. Market Definition
    • 2.3.1. Market Size
    • 2.3.2. Currency
    • 2.3.3. Years
  • 2.4. Methodology
    • 2.4.1. Methodology
    • 2.4.2. Sources
    • 2.4.3. Authors

3. Proteomic Biomarker Analytics - Guide to Technologies

  • 3.1. Methods
    • 3.1.1. Separation techniques and electrophoresis
    • 3.1.2. Mass spectrometry
    • 3.1.3. Chromatography
    • 3.1.4. Blotting
    • 3.1.5. Protein complementation assays and interaction screens
    • 3.1.6. Protein structure prediction
    • 3.1.7. Protein databases

4. Industry Overview

  • 4.1. Players in a Dynamic Market
  • 4.2. Academic Research Lab
  • 4.3. Diagnostic Test Developer
  • 4.4. Instrumentation Supplier
  • 4.5. Chemical/Reagent Supplier
  • 4.6. Pathology Supplier
  • 4.7. Independent Clinical Laboratory
  • 4.8. Public National/regional Laboratory
  • 4.9. Hospital Laboratory
  • 4.10. Physicians Office Lab (POLS)
  • 4.11. Audit Body
  • 4.12. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. Drug Development
    • 5.1.2. Companion Dx
    • 5.1.3. Fertile Research
    • 5.1.4. Technology Convergence
  • 5.2. Factors Limiting Growth
    • 5.2.1. The Cost Curve
    • 5.2.2. Capacity Constraints
    • 5.2.3. Market Lag

6. Proteomic Analytics Recent Developments

  • 6.1. Recent Developments - Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. Sapient Partnering With Alamar Bio to Offer Proteomics
  • 6.3. Spear Bio Funded for Protein-Based Diagnostics
  • 6.4. Salignostics, Sheba Medical Partner on Saliva-Based Cancer Test
  • 6.5. Key Proteo Applies for Newborn Screening Kit to FDA
  • 6.6. Mass Spec Test to Detect Ovarian Cancer
  • 6.7. Proteomic Multiple Sclerosis Test Gaining Traction
  • 6.8. Emory U Protein Panel Could Diagnose Alzheimer's Disease
  • 6.9. Amprion's Parkinson's Disease Dx Shows Strong Performance
  • 6.10. Single-Cell Proteomics Bypasses Bottlenecks
  • 6.11. SomaLogic Seeks 'Strategic Alternatives' for Dx Business
  • 6.12. Alzheimer's Dx Study to Add Genomic, Proteomic Profiling
  • 6.13. NanoDx Prepares for POC Platform Commercialization
  • 6.14. DeepMind AI Predicts 3D Structure of Every Protein
  • 6.15. Quanterix Slashing Workforce by 25 Percent
  • 6.16. Study Shows Potential of NanoMosaic's Platform for Biomarker Development
  • 6.17. Exact Sciences Bolsters Plasma Proteomics Tech With $15M Purchase of OmicEra
  • 6.18. PrognomiQ Exploring Multiomic Markers for Variety of Cancer Dx Applications
  • 6.19. Octave Bioscience Building Evidence Base for Multiple Sclerosis Test
  • 6.20. Proteomics Goes Public

7. Profiles of Key Proteomic Biomarker Analytic Companies

  • 7.1. Abbott Laboratories
  • 7.2. Abcam
  • 7.3. Agilent
  • 7.4. Amprion
  • 7.5. ATUM
  • 7.6. BasePair Biotechnologies
  • 7.7. Beckman Coulter Diagnostics (Danaher)
  • 7.8. Becton, Dickinson and Company
  • 7.9. Biomatik
  • 7.10. Bio-Rad Laboratories, Inc
  • 7.11. Bio-Techne
  • 7.12. Bruker
  • 7.13. C2N Diagnostics
  • 7.14. Cepheid (Danaher)
  • 7.15. Diadem Diagnostics
  • 7.16. Eve Technologies
  • 7.17. Fujirebio
  • 7.18. Hybrigenics Services
  • 7.19. MRM Proteomics Inc.
  • 7.20. NanoDx
  • 7.21. Nautilus Biotechnology
  • 7.22. Nicoya
  • 7.23. Nuclera
  • 7.24. Olink
  • 7.25. Qiagen
  • 7.26. Quanterix
  • 7.27. Roche Diagnostics
  • 7.28. Second Genome
  • 7.29. Siemens Healthineers
  • 7.30. Sphingotec
  • 7.31. Thermo Fisher Scientific
  • 7.32. Unchained Labs

8. Global Proteomic Analytics Markets

  • 8.1. PROTEIN ANALYTICS - Global Market Overview by Country
    • 8.1.1. Table - Global Market by Country
    • 8.1.2. Chart - Global Market by Country
  • 8.2. Global Market by Application - Overview
    • 8.2.1. Table - Global Market by Application
    • 8.2.2. Chart - Global Market by Application - Segments Growth
    • 8.2.3. Chart - Global Market by Application - Base/Final Comparison
    • 8.2.4. Chart - Global Market by Application - Base Year
    • 8.2.5. Chart - Global Market by Application - Final Year
    • 8.2.6. Chart - Global Market by Application - Share by Year
  • 8.3. Global Market by Technology - Overview
    • 8.3.1. Table - Global Market by Technology
    • 8.3.2. Chart - Global Market by Technology - Segments Growth
    • 8.3.3. Chart - Global Market by Technology - Base/Final Comparison
    • 8.3.4. Chart - Global Market by Technology - Base Year
    • 8.3.5. Chart - Global Market by Technology - Final Year
    • 8.3.6. Chart - Global Market by Technology - Share by Year
  • 8.4. Global Market by Product - Overview
    • 8.4.1. Table - Global Market by Product
    • 8.4.2. Chart - Global Market by Product - Segments Growth
    • 8.4.3. Chart - Global Market by Product - Base/Final Comparison
    • 8.4.4. Chart - Global Market by Product - Base Year
    • 8.4.5. Chart - Global Market by Product - Final Year
    • 8.4.6. Chart - Global Market by Product - Share by Year
  • 8.5. Global Market by Place - Overview
    • 8.5.1. Table - Global Market by Place
    • 8.5.2. Chart - Global Market by Place - Segments Growth
    • 8.5.3. Chart - Global Market by Place - Base/Final Comparison
    • 8.5.4. Chart - Global Market by Place - Base Year
    • 8.5.5. Chart - Global Market by Place - Final Year
    • 8.5.6. Chart - Global Market by Place - Share by Year

9. Global PROTEIN ANALYTICS Markets - By Application

  • 9.1. PROTEIN ANALYTICS Drug Discovery
    • 9.1.1. Table PROTEIN ANALYTICS Drug Discovery - by Country
    • 9.1.2. Chart - PROTEIN ANALYTICS Drug Discovery Growth
  • 9.2. PROTEIN ANALYTICS Research Application
    • 9.2.1. Table PROTEIN ANALYTICS Research Application - by Country
    • 9.2.2. Chart - PROTEIN ANALYTICS Research Application Growth
  • 9.3. PROTEIN ANALYTICS Clinical Dx
    • 9.3.1. Table PROTEIN ANALYTICS Clinical Dx - by Country
    • 9.3.2. Chart - PROTEIN ANALYTICS Clinical Dx Growth
  • 9.4. PROTEIN ANALYTICS Other Applications
    • 9.4.1. Table PROTEIN ANALYTICS Other Applications - by Country
    • 9.4.2. Chart - PROTEIN ANALYTICS Other Applications Growth

10. Global PROTEIN ANALYTICS Markets - By Technology

  • 10.1. PROTEIN ANALYTICS Mass Spectrometry
    • 10.1.1. Table PROTEIN ANALYTICS Mass Spectrometry - by Country
    • 10.1.2. Chart - PROTEIN ANALYTICS Mass Spectrometry Growth
  • 10.2. PROTEIN ANALYTICS ELISA/Beads
    • 10.2.1. Table PROTEIN ANALYTICS ELISA/Beads - by Country
    • 10.2.2. Chart - PROTEIN ANALYTICS ELISA/Beads Growth
  • 10.3. PROTEIN ANALYTICS Hybrid Multiplex
    • 10.3.1. Table PROTEIN ANALYTICS Hybrid Multiplex - by Country
    • 10.3.2. Chart - PROTEIN ANALYTICS Hybrid Multiplex Growth
  • 10.4. PROTEIN ANALYTICS Other Technology
    • 10.4.1. Table PROTEIN ANALYTICS Other Technology - by Country
    • 10.4.2. Chart - PROTEIN ANALYTICS Other Technology Growth

11. Global PROTEIN ANALYTICS Markets - By Product

  • 11.1. PROTEIN ANALYTICS Instruments
    • 11.1.1. Table PROTEIN ANALYTICS Instruments - by Country
    • 11.1.2. Chart - PROTEIN ANALYTICS Instruments Growth
  • 11.2. PROTEIN ANALYTICS Kits & Reagents
    • 11.2.1. Table PROTEIN ANALYTICS Kits & Reagents - by Country
    • 11.2.2. Chart - PROTEIN ANALYTICS Kits & Reagents Growth
  • 11.3. PROTEIN ANALYTICS Services
    • 11.3.1. Table PROTEIN ANALYTICS Services - by Country
    • 11.3.2. Chart - PROTEIN ANALYTICS Services Growth

12. Global PROTEIN ANALYTICS Markets - By Place

  • 12.1. PROTEIN ANALYTICS Academic
    • 12.1.1. Table PROTEIN ANALYTICS Academic - by Country
    • 12.1.2. Chart - PROTEIN ANALYTICS Academic Growth
  • 12.2. PROTEIN ANALYTICS Pharma/Biotech
    • 12.2.1. Table PROTEIN ANALYTICS Pharma/Biotech - by Country
    • 12.2.2. Chart - PROTEIN ANALYTICS Pharma/Biotech Growth
  • 12.3. PROTEIN ANALYTICS Clinical
    • 12.3.1. Table PROTEIN ANALYTICS Clinical - by Country
    • 12.3.2. Chart - PROTEIN ANALYTICS Clinical Growth
  • 12.4. PROTEIN ANALYTICS Other Place
    • 12.4.1. Table PROTEIN ANALYTICS Other Place - by Country
    • 12.4.2. Chart - PROTEIN ANALYTICS Other Place Growth

13. Appendices

  • 13.1. Clinical Laboratory Fee Schedule
  • 13.2. The Most Used IVD Assays
  • 13.3. The Highest Grossing Assays
  • 13.4. The Changing IVD Menu
    • 13.4.1. Approved IVD Test Menu History
  • 13.5. The Changing Picture on Reimbursement
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제